| Name | Title | Contact Details |
|---|
About Arrhythmia Research Technology, Inc. The Company through itswholly-owned subsidiary, Micron Products, Inc. manufacturescomponents, devices and equipment primarily for the medical anddefense industries. Micron is engaged in the production and sale ofsilver/silver chloride coated and conductive resin sensors used ascomponent parts in the manufacture of integrated disposableelectrophysiological sensors. These disposable medical devices areused worldwide in the monitoring of electrical signals in variousmedical applications. The Company has expanded into customthermoplastic injection molded products with a full array of design,engineering and production services and management. The addition ofan orthopedic implant machining operation produces quick-turn, highvolume and patient-specific, finished orthopedic implants. TheCompany also has developed and distributes a customizable proprietarysignal-averaging electrocardiography (SAECG) software used in thedetection of certain heart arrhythmias and that is reconfigurable fora variety of hardware platforms.
In 1969, AvMed began in South Florida as Aviation Medicine to serve the growing airline industry by providing pilot physicals. Today, with offices in every major metropolitan area of the state, AvMed aims to inspire its membership of 300,000 Floridians to “Embrace better health.” AvMed provides Medicare Advantage coverage in Broward and Miami-Dade counties, Individual and Family coverage in Broward, Miami-Dade, and Palm Beach counties and Commercial coverage in more than 30 counties across the state. Major employer clients have been partners for decades, a testament to AvMed`s culture of service, which consistenly ranks above statewide peers.
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work environment that is scientifically driven, ambitious, and collaborative. We encourage diversity of thought that leads to great innovation and are looking to add to our dynamic team great people who are driven to transform the lives of patients. We believe our Microbiome platform represents a best in class approach to developing biopharmaceutical agents from live biotherapeutic products. ABI-M201, our lead program in mildly to moderately active ulcerative colitis (UC), is currently in a phase 1b clinical trial. This program is part of a broader collaboration we established with Allergan in 2017 for gastrointestinal programs such as UC, Crohn`s disease and Irritable Bowel Syndromes with potential total development and commercial milestones of up to $2.8 billion. Our internal pipeline comprises first in class or best in class live microbial biotherapeutic approaches in areas such as oncology, immune mediated and metabolic disorders, and other areas of high medical need. Assembly is headquartered in Carmel, Indiana, while the R&D headquarters is in South San Francisco. The Company also has a microbiome manufacturing facility in Groton, CT, and offices in China.
Holy Savior Hospice is a healthcare company that provides compassionate, high quality hospice and palliative care services to patients in Texas.
Wondr Health™ is a digital behavioral change program focused on weight management that helps participants improve their physical and mental wellbeing through simple, interactive, and clinically-proven skills and tools. By treating the root cause of obesity through behavioral science, Wondr reduces risk factors to prevent chronic diseases like diabetes and hypertension, helps enhance employee productivity and engagement, decreases claims costs, and improves overall wellbeing. Wondr Health`s team of renowned doctors and scientists teaches practical, data-backed skills that empower participants to stress less, sleep better, and feel better. The highly personalized program has helped hundreds of thousands of people by teaching employees the science of eating the foods they love so they can still lose weight—regardless of their food preferences, background, or lifestyle, Wondr works for everyone. We`ve been in the benefits space for 15+ years and our clients include many Fortune 500 companies. We currently partner with over 800+ employers, brokers, health plans, and TPAs nationwide. We`ve cracked the code on the science behind improving the health of organizations—with the easiest implementation ever, third-party validated ROI, and clinical results you can count on—Wondr`s a benefit that actually benefits. We`re the ultimate “and” program—we don`t replace your diabetes management or sleep solution. Wondr can work alongside existing benefits as a standalone to enhance the impact of your other point solutions. Through the app, online community, certified coaches, and series of weekly videos that offer a new perspective on better health, participants enter a world where weight loss is a science, small steps lead to big changes, possibilities are infinite, and good habits last.